ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2025, Vol. 34 ›› Issue (6): 532-540.DOI: 10.3969/j.issn.1006⁃298X.2025.06.005

• 论著 • 上一篇    下一篇

磷脂酶 D2 抑制剂 CAY10594 对急性肾损伤的保护作用及其机制

  

  • 出版日期:2025-12-28 发布日期:2025-12-29

Protective effect and mechanism of phospholipase D2 inhibitor CAY10594 on acute kidney injury

  • Online:2025-12-28 Published:2025-12-29

摘要: 目的:探讨磷脂酶 D2 抑制剂 CAY10594 对急性肾损伤(AKI)的保护作用及其潜在机制。方法:通过对脂多糖(LPS)处理后的人源急性单核白血病细胞系(THP-1)进行转录组测序(RNA-seq),筛选差异表达基因,进一步结合连通性图谱(CMap)数据库预测潜在药物分子,筛选出 CAY10594 作为候选干预药物。在 LPS 诱导 C57BL/6 小鼠脓毒症相关 AKI 及肾脏缺血再灌注损伤(IRI)诱导 AKI 两种模型中进行验证,并通过免疫荧光、Western Blot 和 ELISA 等手段评估 CAY10594 的效果。结果:两种 AKI 模型小鼠均出现炎症因子水平升高、肝肾功能损伤及组织病理肾小管损伤。CAY10594 干预显著降低血清炎症因子水平,改善谷丙转氨酶、谷草转氨酶、肌酐及尿素氮水平(P<0.05)。组织病理学检查显示干预组肾小管坏死和巨噬细胞浸润显著减轻,并伴随肾脏 F4/80 阳性巨噬细胞浸润减少及 NOD 样受体家族 pyrin 结构域含 3 型炎症小体(NLRP3)及肾损伤分子 1(KIM-1)表达下调。Western Blot 结果证实,CAY10594 通过抑制核因子 κB(NF-κB)通路的激活,降低 NLRP3 表达及 KIM-1 蛋白水平。结论:CAY10594 通过抑制炎症反应及炎细胞浸润改善 AKI,其可能机制是通过抑制 F4/80-NF-κB-NLRP3 轴来减少巨噬细胞介导的炎症反应,具有潜在的临床应用价值。

关键词: font-family:Inter, -apple-system, BlinkMacSystemFont, ", font-size:16px, background-color:#FFFFFF, ">急性肾损伤、CAY10594、NOD 样受体家族 pyrin 结构域含 3 型炎症小体、巨噬细胞

Abstract: Objective: To investigate the protective effect of the phospholipase D2 inhibitor CAY10594 on acute kidney injury (AKI) and its underlying mechanisms. Methodology: Transcriptional profiling (RNA-seq) was performed on the human acute monocytic leukemia cell line THP-1 treated with lipopolysaccharide (LPS) to identify differentially expressed genes. Potential drug molecules were predicted by integrating the Connectivity Map (CMap) database, and CAY10594 was selected as a candidate intervention. Two AKI models were established: LPS-induced sepsis-related AKI and renal ischemia-reperfusion injury (IRI)-induced AKI in C57BL/6 mice. The effect of CAY10594 was assessed by immunofluorescence, Western blot, and ELISA. Results: Both the LPS and IRI models showed elevated levels of inflammatory cytokines, liver and kidney dysfunction, and renal tubular damage. Treatment with CAY10594 significantly reduced serum inflammatory cytokine levels and improved liver and kidney function markers (ALT, AST, CREA, and UREA, P<0.05). Histopathological examination showed that CAY10594 intervention significantly alleviated tubular necrosis and macrophage infiltration, accompanied by reduced F4/80+ macrophage infiltration and downregulation of NLRP3 and KIM-1 expression in the kidneys. Western blot analysis confirmed that CAY10594 inhibited NF-κB pathway activation, reduced NLRP3 expression, and lowered KIM-1 protein levels. Conclusion: CAY10594 improves acute kidney injury by inhibiting inflammation and inflammatory cell infiltration. Its potential mechanism involves suppression of the F4/80-NF-κB-NLRP3 axis to reduce macrophage-mediated inflammatory responses, suggesting potential clinical applicability.

Key words: font-family:Inter, -apple-system, BlinkMacSystemFont, ", font-size:16px, background-color:#FFFFFF, ">acute kidney injury, CAY10594, NLR family pyrin domain containing 3, macrophage